Literature DB >> 25843644

Could tuning of the inhibitory tone involve graded changes in neuronal chloride transport?

Stefan Titz1, Esther M Sammler2, Sheriar G Hormuzdi3.   

Abstract

Hyperpolarizing synaptic inhibition through GABAA and glycine receptors depends on the presence of the neuronal cation-chloride-cotransporter protein, KCC2. Several transcriptional and post-transcriptional mechanisms have been shown to regulate KCC2 and thereby influence the polarity and efficacy of inhibitory synaptic transmission. It is unclear however whether regulation of KCC2 enables the transporter to attain different levels of activity thus allowing a neuron to modulate the strength of inhibitory synaptic transmission to its changing requirements. We therefore investigated whether phosphorylation can allow KCC2 to achieve distinct levels of [Cl(-)]i in neurons. We generated a variety of KCC2 alanine dephosphorylation mimics and used NH4(+)-induced pHi shifts in cultured hippocampal neurons to quantify the rate of KCC2 transport activity exhibited by these mutants. To explore the relationship between KCC2 transport and GABAA receptor-mediated current amplitudes we performed gramicidine perforated-patch recordings. The correlation between EGABA and NH4(+)-induced pHi shifts enabled an estimate of the range of chloride extrusion possible by kinase/phosphatase regulation of KCC2. Our results demonstrate that KCC2 transport can vary considerably in magnitude depending on the combination of alanine mutations present on the protein. Transport can be enhanced to sufficiently high levels that hyperpolarizing GABAA responses may be obtained even in neurons with an extremely negative resting membrane potential and at high extracellular K(+) concentrations. Our findings highlight the significant potential for regulating the inhibitory tone by KCC2-mediated chloride extrusion and suggest that cellular signaling pathways may act combinatorially to alter KCC2 phosphorylation/dephosphorylation and thereby tune the strength of synaptic inhibition.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  E(GABA); Intracellular chloride; Ion transport; KCC2; Protein phosphorylation; Synaptic inhibition

Mesh:

Substances:

Year:  2015        PMID: 25843644     DOI: 10.1016/j.neuropharm.2015.03.026

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  16 in total

Review 1.  Physiological implications of ocean acidification for marine fish: emerging patterns and new insights.

Authors:  Andrew J Esbaugh
Journal:  J Comp Physiol B       Date:  2017-05-25       Impact factor: 2.200

Review 2.  Kinase-KCC2 coupling: Cl- rheostasis, disease susceptibility, therapeutic target.

Authors:  Kristopher T Kahle; Eric Delpire
Journal:  J Neurophysiol       Date:  2015-10-28       Impact factor: 2.714

3.  N-Ethylmaleimide increases KCC2 cotransporter activity by modulating transporter phosphorylation.

Authors:  Leslie C Conway; Ross A Cardarelli; Yvonne E Moore; Karen Jones; Lisa J McWilliams; David J Baker; Matthew P Burnham; Roland W Bürli; Qi Wang; Nicholas J Brandon; Stephen J Moss; Tarek Z Deeb
Journal:  J Biol Chem       Date:  2017-11-01       Impact factor: 5.157

4.  Targeting ischemia-induced KCC2 hypofunction rescues refractory neonatal seizures and mitigates epileptogenesis in a mouse model.

Authors:  Brennan J Sullivan; Pavel A Kipnis; Brandon M Carter; Li-Rong Shao; Shilpa D Kadam
Journal:  Sci Signal       Date:  2021-11-09       Impact factor: 8.192

5.  Inhibition of the kinase WNK1/HSN2 ameliorates neuropathic pain by restoring GABA inhibition.

Authors:  Kristopher T Kahle; Jean-François Schmouth; Valérie Lavastre; Alban Latremoliere; Jinwei Zhang; Nick Andrews; Takao Omura; Janet Laganière; Daniel Rochefort; Pascale Hince; Geneviève Castonguay; Rébecca Gaudet; Josiane C S Mapplebeck; Susana G Sotocinal; JingJing Duan; Catherine Ward; Arjun R Khanna; Jeffrey S Mogil; Patrick A Dion; Clifford J Woolf; Perrine Inquimbert; Guy A Rouleau
Journal:  Sci Signal       Date:  2016-03-29       Impact factor: 8.192

Review 6.  Preclinical insights into therapeutic targeting of KCC2 for disorders of neuronal hyperexcitability.

Authors:  Phan Q Duy; Miao He; Zhigang He; Kristopher T Kahle
Journal:  Expert Opin Ther Targets       Date:  2020-05-05       Impact factor: 6.902

7.  The effects of chloride dynamics on substantia nigra pars reticulata responses to pallidal and striatal inputs.

Authors:  Ryan S Phillips; Ian Rosner; Aryn H Gittis; Jonathan E Rubin
Journal:  Elife       Date:  2020-09-07       Impact factor: 8.140

8.  Phosphoregulation of the intracellular termini of K+-Cl- cotransporter 2 (KCC2) enables flexible control of its activity.

Authors:  Antje Cordshagen; Wiebke Busch; Michael Winklhofer; Hans Gerd Nothwang; Anna-Maria Hartmann
Journal:  J Biol Chem       Date:  2018-09-10       Impact factor: 5.157

9.  Potentiating KCC2 activity is sufficient to limit the onset and severity of seizures.

Authors:  Yvonne E Moore; Tarek Z Deeb; Heramb Chadchankar; Nicholas J Brandon; Stephen J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-17       Impact factor: 11.205

10.  Staurosporine and NEM mainly impair WNK-SPAK/OSR1 mediated phosphorylation of KCC2 and NKCC1.

Authors:  Jinwei Zhang; Antje Cordshagen; Igor Medina; Hans Gerd Nothwang; Jacek R Wisniewski; Michael Winklhofer; Anna-Maria Hartmann
Journal:  PLoS One       Date:  2020-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.